(Q35136401)

6 August 2017

0 references

Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies (English)

1 reference

6 August 2017

1 reference

1 reference

1 reference

Tian-Bao Huang

1

1 reference

6 August 2017

Zhui-Feng Guo

3

1 reference

6 August 2017

Xiao-Long Zhang

4

1 reference

6 August 2017

Huan Liu

5

1 reference

6 August 2017

Jiang Geng

6

1 reference

6 August 2017

Xu-Dong Yao

7

1 reference

6 August 2017

Jun-Hua Zheng

8

1 reference

6 August 2017

Yang Yan

2

1 reference

6 August 2017

language of work or name

1 reference

1 April 2014

1 reference

International Urology and Nephrology

6 August 2017

1 reference

6 August 2017

46

1 reference

6 August 2017

9

1 reference

6 August 2017

1715-1728

1 reference

Prostate cancer epidemiology in the United States

6 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Cyclooxygenases in cancer: progress and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Aspirin and cancer risk: an updated quantitative review to 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Aspirin and urologic cancer risk: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Regular use of aspirin and prostate cancer risk (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Aspirin use and chronic diseases: a cohort study of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Aspirin, salicylates, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Alcohol and smoking and subsequent risk of prostate cancer in Japanese men: the Japan Public Health Center-based prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

Aspirin and the risk of prostate cancer

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11255-014-0703-4

21 January 2018

12 December 2020

Non-steroidal anti-inflammatory drugs and prostate cancer progression

1 reference

12 December 2020

Association between coronary heart disease and cancers of the breast, prostate, and colon.

1 reference

12 December 2020

Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence

1 reference

12 December 2020

Aspirin use and mortality from cancer in a prospective cohort study

1 reference

12 December 2020

Aspirin use in relation to risk of prostate cancer

1 reference

12 December 2020

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

12 December 2020

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

12 December 2020

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level

1 reference

12 December 2020

Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US

1 reference

12 December 2020

Aspirin use and risk of fatal cancer

1 reference

12 December 2020

Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer

1 reference

12 December 2020

10.1007/S11255-014-0703-4

Identifiers

DOI

1 reference

6 August 2017

1 reference